Public Float. As of the close of trading on Nasdaq on May 6, 2022, the aggregate market value of the outstanding voting and non-voting common equity (as defined in Rule 405) of the Company held by persons other than affiliates of the Company (pursuant to Rule 144 of the Securities Act, those that directly, or indirectly through one or more intermediaries, control, or are controlled by, or are under common control with, the Company) (the “Non-Affiliate Shares”), was approximately $80,500,000 (calculated by multiplying (x) the price at which the common equity of the Company was last sold on Nasdaq on April 8, 2022 by (y) the number of Non-Affiliate Shares outstanding on May 6, 2022). The Company is not a shell company (as defined in Rule 405) and has not been a shell company for at least 12 calendar months previously.
Appears in 2 contracts
Sources: Sales Agreement (Werewolf Therapeutics, Inc.), Sales Agreement (Werewolf Therapeutics, Inc.)
Public Float. As of the close of trading on Nasdaq on May 6March 31, 20222024, the aggregate market value of the outstanding voting and non-voting common equity (as defined in Rule 405) of the Company held by persons other than affiliates of the Company (pursuant to Rule 144 of the Securities Act, those that directly, or indirectly through one or more intermediaries, control, or are controlled by, or are under common control with, the Company) (the “Non-Affiliate Shares”), was approximately $80,500,000 237,824,948 (calculated by multiplying (x) the price at which the common equity of the Company was last sold on Nasdaq on April 8March 31, 2022 2024 by (y) the number of Non-Affiliate Shares outstanding on May 6March 31, 20222024). The Company is not a shell company (as defined in Rule 405) and has not been a shell company for at least 12 calendar months previously.
Appears in 1 contract
Public Float. As of the close of trading on Nasdaq on May 6June 30, 2022, the aggregate market value of the outstanding voting and non-voting common equity (as defined in Rule 405) of the Company held by persons other than affiliates of the Company (pursuant to Rule 144 of the Securities Act, those that directly, or indirectly through one or more intermediaries, control, or are controlled by, or are under common control with, the Company) (the “Non-Affiliate Shares”), was approximately $80,500,000 59,925,142 (calculated by multiplying (x) the price at which the common equity of the Company was last sold on Nasdaq on April 8May 25, 2022 by (y) the number of Non-Affiliate Shares outstanding on May 6June 30, 2022). The Company is not a shell company (as defined in Rule 405) and has not been a shell company for at least 12 calendar months previously.
Appears in 1 contract